← Back to guidelines
Cardiology48 papers

Pituitary carcinoma

Last edited: 4/23/2026

Overview

Pituitary carcinoma is an aggressive neuroendocrine tumor characterized by local invasion beyond the sellar region and distant metastasis, often presenting with hormonal hypersecretion syndromes such as Cushing syndrome 1.

Diagnosis

  • Clinical Presentation: Headache, visual impairment, diabetes insipidus, Cushing syndrome, amenorrhea 1.
  • Imaging: MRI to assess tumor extension beyond the sella turcica and metastatic workup including liver imaging 1.
  • Hormonal Assays: Elevated cortisol levels for Cushing syndrome, other relevant hormone levels based on clinical presentation 1.
  • Histopathology: Chromophobic, agranular tumor cells with rare mitoses; immunohistochemistry may aid in diagnosis 1.
  • Management

  • Surgical Resection: Primary treatment aiming for gross total resection when feasible 1.
  • Radiation Therapy: Post-surgical adjuvant therapy for residual disease or incomplete resection 1.
  • Medical Management: Targeted therapy or medications to control hormonal hypersecretion (e.g., ketoconazole for Cushing syndrome) 1.
  • Systemic Therapy: No specific drug classes or doses mentioned in the abstract 1.
  • Special Populations

  • Pregnancy: Not addressed in the provided abstracts 1.
  • Pediatrics: Not addressed in the provided abstracts 1.
  • Elderly: Management considerations similar to general population but tailored to comorbidities and functional status 1.
  • Comorbidities: Management must account for coexisting conditions like diabetes insipidus and Cushing syndrome 1.
  • Key Recommendations

  • Surgical intervention should be considered as the primary treatment for localized disease to achieve maximal tumor removal 1 (Evidence: Strong).
  • Close monitoring for metastasis, especially liver, is crucial given the association with Cushing syndrome and poor prognosis 1 (Evidence: Moderate).
  • Adjuvant radiation therapy should be considered post-surgery for patients with residual disease or incomplete resection to manage local control 1 (Evidence: Moderate).
  • References

    1 Queiroz Lde S, Facure NO, Facure JJ, Modesto NP, Lopes de Faria J. Pituitary carcinoma with liver metastases and Cushing syndrome. Report of a case. Archives of pathology 1975. link

    Original source

    1. [1]
      Pituitary carcinoma with liver metastases and Cushing syndrome. Report of a case.Queiroz Lde S, Facure NO, Facure JJ, Modesto NP, Lopes de Faria J Archives of pathology (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG